A further exploration of the potential mechanisms of ZNF385A and ZNF346 showed that they may not only be involved in the regulation of tumorigenesis and the development of HCC, but they may also be correlated with an inflammatory immunosuppressive TME and exert a predictive effect on the response to immunotherapy. The gene discussed is ZNF346; the disease is hepatocellular carcinoma.